Silverstein M N
Postgrad Med. 1977 Feb;61(2):206-10. doi: 10.1080/00325481.1977.11712127.
The various myeloproliferative diseases have different symptoms, therapeutic problems, and prognoses. The most common of these disorders appears to be agnogenic myeloid metaplasia, which primarily affects older persons. The five-year survival rate at the Mayo Clinic for these patients is 58%, and the prognosis depends on the presence of symptoms, anemia, and thrombocytopenia and on the size of the liver. Androgen therapy is often necessary to control anemia, and splenectomy may be indicated.
各种骨髓增殖性疾病有不同的症状、治疗问题和预后。这些疾病中最常见的似乎是原因不明的髓样化生，主要影响老年人。在梅奥诊所，这些患者的五年生存率为58%，预后取决于症状、贫血、血小板减少症的存在以及肝脏的大小。通常需要雄激素疗法来控制贫血，可能需要进行脾切除术。
